The Epidermis as a Bioreactor: Topically Regulated Cutaneous Delivery into the Circulation
Authors:
- 10 June 2002
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 13 (9) , 1075-1080
Abstract
Previous studies have documented that the skin can be used as a bioreactor to produce proteins for systemic release to treat diseases. A gene-switch system has been developed that allows regulated expression of therapeutic genes. To determine whether this system could be used in the skin, we developed a transgenic mouse model in which expression of a therapeutic gene could be topically induced in epidermal keratinocytes. After a single induction, high levels of the therapeutic protein, human growth hormone (hGH), were released from keratinocytes into the circulation. The serum levels of hGH were dependent on the amount of inducer applied, and repeated induction resulted in increased weight gain by transgenic versus control mice. Furthermore, physiological levels of hGH were detected in the serum of nude mice after topical induction of small transgenic skin grafts. These results clearly demonstrate the feasibility of using the gene-switch system to regulate the delivery of therapeutic proteins into the circulation via genetically modified keratinocytes.Keywords
This publication has 20 references indexed in Scilit:
- Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skinBlood, 2000
- Development of gene-switch transgenic mice that inducibly express transforming growth factor β1 in the epidermisProceedings of the National Academy of Sciences, 1999
- Systemic Replacement Therapy from Genetically Modified Epidermal KeratinocytesProceedings of the Association of American Physicians, 1999
- Gene Therapy for Genetic Skin DiseaseJournal of Investigative Dermatology, 1998
- Ligand-inducible and liver-specific target gene expression in transgenic miceNature Biotechnology, 1997
- Transgenic studies with a keratin promoter-driven growth hormone transgene: Prospects for gene therapyProceedings of the National Academy of Sciences, 1997
- Overexpression of anAgouticDNA in the Skin of Transgenic Mice Recapitulates Dominant Coat Color Phenotypes of Spontaneous MutantsDevelopmental Biology, 1996
- A regulatory system for use in gene transfer.Proceedings of the National Academy of Sciences, 1994
- Towards gene therapy for haemophilia B using primary human keratinocytesNature Genetics, 1993
- The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptorCell, 1992